Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 23 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

    Rochester, MN

  2. Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Subjects With SCN8A-DEE

    Rochester, MN

  3. Genetic Markers of Cardiovascular Disease in Epilepsy

    Rochester, MN

  4. A Study to Evaluate Newly-diagnosed Idiopathic Generalized Epilepsy

    Rochester, MN

  5. A Study of Mood Symptoms in Epilepsy Patients

    Rochester, MN

  6. Remote Home-Based Monitoring Using Radio Signal Characterization of Seizures

    Rochester, MN

  7. Human Blood and Tissues Repository for Neuroscience Research

    Jacksonville, FL

  8. Multiscale EEG Dynamics

    Rochester, MN, Scottsdale/Phoenix, AZ

  9. Human Brain Mapping to Understand Mechanisms of Learning, Memory, and Cognition

    Jacksonville, FL

  10. A Study to Evaluate Biomarker Target Stimulation

    Rochester, MN

.

Mayo Clinic Footer